• 250258181841251291119430831882822PublicAssets/2579
    Bottles of warfarin
    Active
    View Entry

    Large-Resolution Image
    250 x 258 pixels
    1 × 1 inches (300 dpi)
    17.8kb

    Medium-Resolution Image
    125 x 129 pixels
    1 × 1 inches (150 dpi)
    10.9kb

    Low-Resolution Image
    308 x 318 pixels
    4 × 4 inches (72 dpi)
    80.9kb

    Bottles of warfarin

    2579

    In 2007, the FDA modified warfarin's label to indicate that genetic makeup may affect patient response to the drug. The widely used blood thinner is sold under the brand name Coumadin®. Scientists involved in the NIH Pharmacogenetics Research Network are investigating whether genetic information can be used to improve optimal dosage prediction for patients.
    Public Note
    Internal NoteNews release: http://www.nigms.nih.gov/News/Results/Warfarin02182009.htm
    Keywords
    SourceAlisa Machalek, NIGMS/NIH
    Date2009-02-20 00:00:00
    Credit LineAlisa Machalek, NIGMS/NIH
    Investigator
    Record TypePhotograph
    Topic Area(s);#Chemistry, Biochemistry, and Pharmacology;#Genes;#
    Previous Uses2/18/2009 NIGMS news release. 2/09 BB
    StatusActive

    View All Properties
    Edit Properties

Add New Version

Note: Uploading a version which already exists will overwrite the existing version with the uploaded file.
* Uploaded thumbnails wider than 120 pixels will be reduced.